Allogene Therapeutics (ALLO) FCF yield US GAAP (year values) |
|||||||||
2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
FCF yield, % | ? | -7.17% | -5.96% | -10.2% | -25.1% | -47.5% | -45.3% | ||
Changes by years, y/y, % | -1pp | +1pp | -4pp | -15pp | -22pp | +50.5% |
Allogene Therapeutics. FCF yield, %
Allogene Therapeutics. FCF yield, changes, pp
Allogene Therapeutics (ALLO) FCF yield US GAAP (quarter values) |
||||||||
2023Q1 | 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | LTM ? | |||
FCF yield, % | ? | -31.3% | -33.1% | -46.9% | -44.3% | -30.1% | -45.3% | |
Changes by years, y/y, % | -14pp | -20pp | -33pp | -19pp | +1pp | |||
Changes by quarters, q/q, % | -6pp | -2pp | -14pp | +3pp | +14pp |